Assignment - Due Last Friday of the Semester
This is not a typical writing assignment, so do not
treat it as such. The intent is for you to do
your very best work. The paper
in should demonstrate that you truly understand and can apply what you
learned in this course. It should reveal your ability to reflect on a
scientific topic and communicate it visually and in writing to others
meaningful context. It is an opportunity to display your ability to
and explore personal learning issues, to find and assimilate relevant
information from the scientific literature, and then synthesize
a meaningful paper that is not just a term paper. If done well, you
to include your paper in an online portfolio to demonstrate that you
achieved the standards expected of you at the
Background for the Assignment: Linus Pauling introduced the concept of molecular disease by demonstrating that the gene for sickle cell anemia was directly related to a chemical alteration of hemoglobin in the red blood cells of affected individuals. A few years later, Vernon Ingram identified a single amino acid replacement at position 6 of the beta chains of sickle cell hemoglobin (HbS) and showed that the sequence of the remaining 145 amino acids of the beta chains and all 141 amino acids in the alpha chains of hemoglobin were unchanged compared to normal hemoglobin (HbA). Subsequently, others determined the exact nucleotide substitution mutation in the beta globin gene possessed by sickle cell patients.
These discoveries prompted a stampede of sorts to discover other hemoglobin variants and the corresponding mutations in DNA. There are now on the order of 1000 different mutations known to affect the amino acid sequence or production of hemoglobin. While many of these are single-nucleotide-substitution mutations, deletions, and insertions that have little or no clinical effects, the consequences of others vary from benign to severe, as in the case of thalassemias. Many medical biochemists have made a career studying these usually rare hemoglobinopathies.
Using a list of hemoglobinopathies (alpha-chain, beta-chain, thalassemias), pick an interesting example to investigate as the basis for a 5-10 page, double-spaced, well-organized report. Select a variant that no one else in class has selected. Your report should have the following elements:
Each group should arrange a time to meet for 30-60 minutes with Catherine Wojewodzki, a science librarian in 117C Morris Library (831-4240, or Cathyw at udel.edu) who is familiar with this project and can provide assistance in tracking down the information you need. In the past, students have had problems because they did not take full advantage of the resources available. You will need to develop these library research skills as part of your undergraduate education. (They go well beyond "Googling" the Internet.)
Cathy Wojewodzki normally likes to work with <12 students at a time. This year, there will be three consecutive time slots on Monday, April 11, 8:00-8:30; 8:30-9:00; and 9:00–9:30 AM.
Cathy will work with you on your actual Hb variants. If you make your selection and get it approved before you attend this session, you will not have to repeat the work. Groups will meet in Room 116B in Morris Library Reference Room area and use the laptop computers in there. You are welcome to bring your own, if you prefer.
This assignment will be evaluated for its composition, content, clarity of presentation, and depth of your analysis. An "A paper" must go beyond simple reporting of information. For example, a molecular graphics representation of your hemoglobin variant showing the location of any mutational modification, but make sure it shows something worth seeing. Remember, this should be your synthesis of the information, not a paraphrasing words by others. Late papers will not be accepted without a grade penalty.
Other Options: Students who would rather explore aspects of hemoglobin function, evolution, or properties of unusual hemoglobins from other species may do so in consultation with Dr. White. There are related topics available such as Glucose-6-P deficiency (favism).Suggestions:
3. Feel free to discuss your ideas and any
difficulties you have with me (Dr. White) preferably well before the
|Hb Lepore (Boston-Washington)- JMa||Beta Chain Variants
|Hb H - KHu||Hb D-Los Angeles - MW||Hb Bruxelles - beta F42del - TPh||Other topics
|Hb Barts - AL||Hb Raleigh beta V1A - EH||Hb Korle-Bu - beta D73N - JQ||Hb F - HK|
||Hb Deer Lodge - beta H2R - MWy||Hb Providence - beta K82N - HS||Erythropoetin - ME|
|Alpha Chain Variants
||Hb G- San Jose - betaE7G - SS||Hb Chesapeake - alpha R92L - VB||Fish Hb - Root Effect - BB|
|Hb Taybe - alpha 38-39del - EB||Hb Porto Alegre - beta S9C - RM||Hb Gun Hill - beta 91-95 del - AJ||Hb evolution at high altitude - TPe|
G Philadelphia alpha N68K - JF
||Hb Olympia - beta V20M - KHo||Hb Nottingham - beta V98G - SL||Methemoglobinemia - JR|
|Hb Q-Thailand - alpha D74H - CE||Hb Strasbourg - beta V23D - JT||Hb Koln - beta V98M - SK||Hb-Band 3 interaction - MS|
|Hb Bibba - alpha L136P - JZ||Hb E - beta E26K - KB||Hb O Arab - beta E121K - CH||Leghemoglobin - CA
|Hemoglobin H - Constant Spring - alpha term142Q - MP||Hb-C
Harlem beta E6K&D73N - JB
||Neuroglobin - JMc